Refractory Non-Small Cell Lung Cancer
1 clinical trials · Condition
◉ Watch Refractory Non-Small Cell Lung Cancer
| Record | Firm | Date |
|---|---|---|
| Anti-CD38 Antibody With KRAS Vaccine and Anti-PD-1 Antibody in Subjects With Pancreatic Ductal Adenocarcinoma and Refractory Non-Small Cell Lung Cancer (NCT06015724) | Georgetown University | 2024-01-31 |
Track Refractory Non-Small Cell Lung Cancer automatically
Every clearance here is in the API, with alerts when new ones post.